Boardroom Alpha
Start trial
10-Q primary document
AHCO · Quarterly Report (Form 10-Q) · Filed August 4, 2026

Adapthealth Corp — 10-Q exhibit

ahcosupplementalindenturet.htm
Adapthealth Corp on Boardroom Alpha
Document
Exhibit 4.1
SUPPLEMENTAL INDENTURE
TO BE DELIVERED BY SUBSEQUENT GUARANTORS

Supplemental Indenture (this “Supplemental Indenture”), dated as of May 28, 2026, among Cair Respiratory Services LLC, AdaptHealth West, LLC, Verus Healthcare Holdings LLC, Fletcher's Medical Supplies, Inc., Community Surgical Supply of Toms River, LLC, Ocean Breeze Infusion Care, LLC, Olympia Respiratory Services, LLC, Home Medical Products and Services, LLC, Pumps It, Inc. (the “Guaranteeing Subsidiaries”), each of which is a subsidiary of AdaptHealth LLC, a Delaware limited liability company (the “Company”), the Company, and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”).

W I T N E S S E T H
WHEREAS, each of the Company and the Guarantors (as defined in the Indenture referred to below) has heretofore executed and delivered to the Trustee an indenture, dated as of July 29, 2020, (as amended and supplemented, the “Indenture”)providing for the issuance of an unlimited aggregate principal amount of 6.125% Senior Notes due 2028 (the “Notes”);

WHEREAS, the Indenture provides that under certain circumstances each of the Guaranteeing Subsidiaries shall execute and deliver to the Trustee a supplemental indenture pursuant to which each of the Guaranteeing Subsidiaries shall unconditionally Guarantee all of the Company’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein and under the Indenture; and

WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is
hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders as follows:

1.Capitalized Terms. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

2.Guarantor. Each of the Guaranteeing Subsidiaries hereby agrees to be a Guarantor under the Indenture and to be bound by the terms of the Indenture applicable to Guarantors, including Article 11 thereof.

3.Governing Law. THIS SUPPLEMENTAL INDENTURE WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

4.Waiver of Jury Trial. EACH OF THE GUARANTEEING SUBSIDIARIES AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE INDENTURE, THE NOTES, THE NOTE


GUARANTEES OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.

5.Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.

6.Headings. The headings of the Sections of this Supplemental Indenture have been inserted for convenience of reference only, are not to be considered a part of this Supplemental Indenture and shall in no way modify or restrict any of the terms or provisions hereof.






































IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first

CAIR RESPIRATORY SERVICES LLC
By: /s/ Jason Clemens
Name: Jason Clemens
Title: Chief Financial Officer

ADAPTHEALTH WEST, LLC
By: /s/ Jason Clemens
Name: Jason Clemens
Title: Chief Financial Officer

VERUS HEALTHCARE HOLDINGS LLC
By: /s/ Jason Clemens
Name: Jason Clemens
Title: Chief Financial Officer

FLETCHER’S MEDICAL SUPPLIES, INC.
By: /s/ Jason Clemens
Name: Jason Clemens
Title: Chief Financial Officer

COMMUNITY SURGICAL SUPPLY OF TOMS RIVER, LLC
By: /s/ Jason Clemens
Name: Jason Clemens
Title: Chief Financial Officer

OCEAN BREEZE INFUSION CARE, LLC
By: /s/ Jason Clemens
Name: Jason Clemens
Title: Chief Financial Officer

OLYMPIA RESPIRATORY SERVICES, LLC
By: /s/ Jason Clemens
Name: Jason Clemens
Title: Chief Financial Officer

HOME MEDICAL PRODUCTS AND SERVICES, LLC
By: /s/ Jason Clemens
Name: Jason Clemens
Title: Chief Financial Officer

PUMPS IT, INC.
By: /s/ Jason Clemens
Name: Jason Clemens
Title: Chief Financial Officer




THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
By: /s/ April Bradley
Name: April Bradley
Title: Vice President

ADAPTHEALTH LLC
By: /s/ Jason Clemens
Name: Jason Clemens
Title: Chief Financial Officer


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer